UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.
Related Articles

News
UC San Diego Students to Compete in Sustainability Decathlon
July 7, 2022
sandiegobiotech
News, UCSD News
Comments Off on UC San Diego Students to Compete in Sustainability Decathlon
With the affordable housing crisis reaching a fever pitch in San Diego and the impacts of climate change being felt around the world, a team of students at UC San Diego is putting their skills to work as they de… […]

News
Innovate to Dominate
A new book from Tai Ming Cheung, “Innovate to Dominate: The Rise of the Chinese Techno-Security State,” examines the convergence of national security, innovation and economic development in China, detailing the … […]

News
With Time and Without Masks, COVID-19 Vaccines Wane in Protection
September 1, 2021
sandiegobiotech
News, UCSD News
Comments Off on With Time and Without Masks, COVID-19 Vaccines Wane in Protection
A study measured effectiveness of COVID-19 mRNA vaccines among health workers, most notably during the emergence of delta virus variant and coincident with end of state’s mask mandate, finding protection waned o… […]